Governors Take Aim At FDA For Not Releasing Follow-On Biologics Guidances

A bipartisan group of four governors are accusing FDA of violating the Administrative Procedure Act by not issuing guidance documents on therapeutically equivalent versions of insulin and human growth hormone products